1YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
Disperse Yellow Impurity 4 | 2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethyl acetate | 15141-18-1 |
Alendronic Acid Impurity 10 | N-乙酰氨甲基膦酸 | 57637-97-5 |
PentacyanoaMine Ferrate AMMoniuM DisodiuM Salt | 二钠五氰氨络物高铁酸盐铵 | 36682-41-4 |
Fumagillin Impurity 1 | O-(氯乙酰氨甲酰基)烟曲霉素醇 | 129298-91-5 |
Azilsartan Impurity 121 | 阿齐沙坦杂质121 | 1613135-56-0 |
Arginine Impurity 23 | L-Argininamide, N2-(1-oxooctadecyl)-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl- | 383177-47-7 |
Bilastine Impurity 34 | 2-[4-(2-氯乙酰基)苯基]-2-甲基丙酸甲酯 | 1638785-19-9 |
Ritlecitinib Impurity 2 | N-BOC-6-甲基-3-氨基吡啶 | 323578-37-6 |
Ritlecitinib Impurity 4 | 2101218-65-7 | 2101218-65-7 |
Ritlecitinib | 利特昔替尼 | 1792180-81-4 |
Ammonium hexafluorosilicate | 氟硅酸铵 | 16919-19-0 |
Diltiazem Impurity 6 Monomer | 去乙酰地尔硫卓 | 42399-40-6 |
Tiaprofenic Acid Impurity 7 | 2,4,6-三甲基苯甲酸 | 480-63-7 |
Tosufloxacin p-Toluenesulfonate | 甲苯磺酸妥舒沙星 | 115964-29-9 |
Prusogliptin Impurity 17 | N-BOC-反式-4-羟基-D-脯氨酰胺 | 1613482-41-9 |
Diclofenac Impurity 15-d4 | 4-羟基双氯芬酸-D4 | 254762-27-1 |
Lansoprazole Impurity 94 | 地兰索拉唑杂质7 | 1781244-56-1 |
Docetaxel Impurity 65 | (3R,4S)-3-(三乙基硅氧基)-4-苯基-2-氧-氮杂环丁-1-甲酸叔丁酯 | 149198-47-0 |
3-(2,4-dimethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-Benzenamine | 3-胍基-4-甲基苯甲酸 | 859026-97-4 |
Dopamine Impurity 82 | 2-甲氧基-5-(2-硝基乙烯基)苯酚 | 39816-35-8 |
Relugolix Impurity 147 | 瑞卢戈利杂质65 | 2591260-03-4 |
Ifosfamide Impurity 16 | N-甲基-2-羟基乙胺 | 109-83-1 |
Galantamine Impurity 12 | 二氢加兰他敏盐酸盐 | 21041-10-1 |
3-(2-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl)aniline | 2-氨基-4-甲基苯甲酸乙酯 | 64818-80-0 |
Donepezil Impurity 67 | 3,4-二甲氧基肉桂酸 | 6443-72-7 |
Domperidone Impurity 19 | 吗丁啉杂质12 | 107618-26-8 |
Icotinib Impurity 4 | 埃克替尼杂质4 | 1058651-82-3 |
Icotinib Impurity 3 | 埃克替尼杂质3 | 1643673-51-1 |
Icotinib Impurity 19 | 埃克替尼杂质19 | 1318600-10-0 |
Icotinib Impurity 5 | 埃克替尼杂质5 | 2249867-59-0 |
Sarolaner Impurity 6 | 1398608-99-5 | |
Sarolaner Impurity 4 | 1398609-88-5 | |
Sarolaner Impurity 3 | 2131160-99-9 | |
Sarolaner Impurity 28 | 1575831-00-3 | |
Icotinib Impurity 18 | Icotinib Impurity 5 | 1318600-04-2 |
Icotinib Impurity 17 | 埃克替尼杂质17 | 2376901-55-0 |
Icotinib Impurity 15 | 埃克替尼杂质15 | 1887066-21-8 |
Vardenafil Monomer | 伐地那非 | 224785-90-4 |
Levodropropizine Impurity 37 | 哌嗪-1,4-二乙酸 | 5430-78-4 |
Pentoxyverine Monomer | 枸橼酸喷托维林 | 77-23-6 |
Benproperine Monomer | 苯丙哌林 | 2156-27-6 |
Rosiglitazone Maleate | 马来酸罗格列酮 | 155141-29-0 |
Benzenesulfonic Acid Impurity 48 | 苯磺酸杂质48 | 3939-71-7 |
Icotinib Impurity 1 | Icotinib Impurity 1 | 1058651-74-3 |
Secobarbital Sodium Salt | 司可巴比妥钠盐 | 309-43-3 |
Palbociclib Impurity 166 | 4-(6-Amino-pyridin-2-yl)-piperazine-1-carboxylic acid tert-butyl ester | 1206248-85-2 |
Sitagliptin Impurity 28 | 西他列汀杂质28 | 898543-70-9 |
Clozapine Impurity 11 | 氯氮平杂质 | 1977-07-7 |
Creatine Phosphate Impurity 30 | 磷酸肌酸杂质1 | 98924-69-7 |
Caprylic Acid Impurity 78 | 4,5,5,5-TETRAFLUORO-4-(TRIFLUOROMETHYL)-2-PENTENOIC ACID | 243139-64-2 |
Caprylic Acid Impurity 81 | 5,5,5-Trifluoropent-2-enoic acid | 1314994-88-1 |
Crisaborole Impurity 101 | 2-溴-3-羟基苯甲醛 | 196081-71-7 |
Crizotinib Impurity 13 | 4-(4-溴吡唑-1-基)哌啶-1-甲酸叔丁酯 | 877399-50-3 |
Dabigatran Impurity 138 | 氯甲酸正己酯 | 6092-54-2 |
Cyclobenzaprine Impurity 16 | 环苯扎林杂质7 | 1614-63-7 |
Catechin Impurity 14 | 2-(3,4-二羟基苯基)-2-((2-(3,4-二羟基苯基)-5,7-二氢色满-3-基)氧基)苯并二氢吡喃-3,4,5,7-四醇 | 20347-71-1 |
Anagrelide Hydrochloride Hydrate | ANAGRELIDE HCL MONOHYDRATE | 823178-43-4 |
Icotinib Impurity 21 | 埃克替尼杂质21 | 1708935-20-9 |
Sarolaner Impurity 1 | / | 1398609-00-1 |
Icotinib Impurity 8 | 埃克替尼杂质8 | 153437-34-4 |
Icotinib Impurity 10 | 埃克替尼杂质10 | 2376901-56-1 |
Icotinib Impurity 13 | 610798-18-0 | 610798-18-0 |
Icotinib Impurity 14 | 埃克替尼杂质14 | 1887066-23-0 |
Butenafine Impurity 77 | 1,8-二氯萘 | 2050-74-0 |
Fenfluramine Hydrochloride | 盐酸芬氟拉明 | 404-82-0 |
Buprenorphine Impurity 26 | 叔丁啡杂质26 | 209963-02-0 |
Phloroglucinol Impurity 202 Hydrate | 27735-64-4 | |
Isocitric Acid Trisodium Salt | 异柠檬酸三钠盐 | 1637-73-6 |
Bixalomer Impurity 1 | 比沙洛姆杂质1 | 120239-62-5 |
5,8-Dibromo-1,2,3,4-tetrahydroquinoline | 7-溴-5-氯-8-羟基喹啉 | 7640-33-7 |
Azithromycin Impurity 68 | Azithromycin Impurity 11 | 217500-34-0 |
Sofosbuvir Impurity 146 | 1-[2-deoxy-3,5-di-O-(p-chlorobenzoyl)-β-D-erythropentofuranosyl]-5-trifluoromethyl uracil | 129664-47-7 |
Sorafenib Impurity 117 | 6-氯-2-吡啶羧酸甲酯 | 6636-55-1 |
Acetylsalicylic Acid Impurity 27 | 3-甲酰基-4-羟基苯甲酸 | 584-87-2 |
Bixalomer | N,N,N',N'-四(3-氨基丙基)-1,4-丁二胺 2-(氯甲基)环氧乙烷聚合物 | 851373-13-2 |
Morphine Hydrochloride Impurity 2 Hydrate(Morphine Hydrochloride EP Impurity B Hydrate) | MORPHINE RELATED COMPOUND B CII | 6472-73-7 |
Sarolaner Impurity 54 | 1575809-02-7 | |
Sarolaner Impurity 53 | 1398609-12-5 | |
Dapoxetine Impurity 116 | 达泊西汀杂质45 | 691-93-0 |
Dapoxetine Impurity 114 | N,N-二甲基-1-萘胺 | 86-56-6 |
Desloratadine-d5 | 地氯雷他定D5 | 1020719-34-9 |
Dasatinib Impurity 99 | 4,6-二氯-2-甲基嘧啶 | 1780-26-3 |
1,2-Ethanediylbis[nitrilobis-(methylene)]]tetrakis-phosphonic acid | 乙二胺四亚甲基膦酸 | 1429-50-1 |
Esmolol Impurity 67 | 肉桂酸 | 621-82-9 |
Dicarboxylic acids, C4-6 | 草酸标准溶液 | 68603-87-2 |
Dapoxetine Impurity 1 | 达泊西汀杂质1 | 119357-22-1 |
Dapoxetine Impurity 110 | 达泊西汀杂质 | 1329834-62-9 |
Yohimbine Monomer | 育亨宾 | 146-48-5 |
Darunavir Impurity 20 | 地瑞那韦杂质 19 | 1402142-62-4 |
Darunavir Impurity 18 | 达鲁那韦杂质7(S,S-异构体) | 192800-79-6 |
Lemborexant Impurity 1 | 莱博雷生中间体 | 528587-70-4 |
Milnacipran Impurity 13 | Milnacipran Related Compound A (25 mg) (2-(Aminomethyl)-1-phenylcyclopropane-1-carboxylic acid hydrochloride) | 871100-19-5 |
Amino tris(methylene phosphonic acid) | 氨基三亚甲基膦酸 | 6419-19-8 |
Dasatinib Impurity 91 | 2,3-二氯-6-甲基苯胺 | 62077-27-4 |
Dasatinib Impurity 90 | 2,4-二氯-6-甲基苯胺 | 30273-00-8 |
Darunavir Impurity 21 | 达鲁那韦杂质9 | 1932330-83-0 |
Butenafine Impurity 86 | 光蜡1013 | 1321-64-8 |
Butenafine Impurity 80 | 1,2,3,5-TETRACHLORONAPHTHALENE | 53555-63-8 |
Butenafine Impurity 79 | 1,2,3-TRICHLORONAPHTHALENE | 50402-52-3 |
Adrenaline Impurity 15 Hydrochloride | RAC N-甲基肾上腺素盐酸盐 | 62-22-6 |
联系方式